Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Zanganeh Mahkam. Director active across 2 companies, notably Summit Therapeutics Inc.. Aggregated, 15 disclosures have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €37.7m. Activity tracked since 8 March 2023. The latest transaction was disclosed on 10 September 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Zanganeh Mahkam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Zanganeh Mahkam is a declarant linked to Summit Therapeutics Inc. and Pulse Biosciences, INC., with 13 filings in total. Across the 13 recent filings we hold, buys amount to EUR 32683908, sells to EUR 0, and the period runs from 2022-12-09 to 2025-04-09.